US to Phase Out $45 Million in Annual Support for Namibia HIV Programs/ TezzBuzz/ WASHINGTON/ J. Mansour/ The United States will provide Namibia with $45 million for HIV programs in fiscal 2027 before transitioning from direct funding to technical assistance. The change follows Namibia’s rejection of proposed provisions for sharing health data and biological specimens, citing privacy, sovereignty and legal concerns.
Namibia has surpassed global treatment targets, but the transition is part of a wider reduction in American HIV assistance across southern Africa.
Quick Look
- Namibia will receive $45 million in U.S. HIV funding for fiscal 2027.
- Direct American financial assistance will then begin to end.
- Future U.S. support will focus on “technical cooperation.”
- Washington has provided more than $1.1 billion to Namibia’s HIV response since 2003.
- Namibia rejected proposed health-data and biological-specimen provisions.
- The two governments are negotiating a new bilateral health agreement.
- Namibia has achieved HIV benchmarks of 96%-98%-98%.
- The global UNAIDS target is 95%-95%-95%.
- Similar U.S. health agreements have faced resistance elsewhere in Africa.
- Washington is also withdrawing more than $400 million annually from South African HIV programs.
Deep Look
US Begins Transition Away From Direct HIV Funding
WINDHOEK, Namibia — The United States will begin phasing out approximately $45 million in annual support for Namibia’s HIV programs as the southern African country assumes responsibility for financing its national response.
Washington will provide $45 million during the 2027 fiscal year. After that, Namibia will increasingly fund its own programs, while American involvement shifts toward “technical cooperation,” according to a joint statement from the two governments.
The transition is expected to take place over the coming year as HIV services are integrated more fully into Namibia’s national healthcare system.
More Than $1.1 Billion Provided Since 2003
Namibia has received roughly $45 million annually in recent years through the U.S. President’s Emergency Plan for AIDS Relief, widely known as PEPFAR.
The United States says it has contributed more than $1.1 billion to Namibia’s HIV response since PEPFAR was established in 2003.
The two governments presented the transition as recognition of Namibia’s growing ability to manage its response domestically and its success in bringing the epidemic under control.
“Over the next year, this support will transition into a technical cooperation model as the HIV response is fully integrated into Namibia’s sustainable national health system, in line with Namibia’s national laws,” the governments said.
Namibia Surpasses UNAIDS Targets
Namibia has surpassed the international HIV benchmarks established by UNAIDS.
According to the joint statement:
- 96% of people living with HIV know their status.
- 98% of those diagnosed are receiving treatment.
- 98% of those receiving treatment have achieved viral suppression.
The corresponding UNAIDS goals are 95%, 95% and 95%.
Viral suppression means treatment has reduced the amount of HIV in a person’s blood to a very low level, helping protect the individual’s health and preventing sexual transmission.
The governments said Namibia’s results demonstrate that the country has achieved epidemic control and possesses the institutional capacity to maintain those gains.
Health-Data Dispute Preceded Funding Change
The withdrawal was anticipated following the Trump administration’s adoption of an “America First” approach to foreign assistance. It also comes after Namibia rejected proposed provisions concerning the transfer of health information and biological specimens to the United States.
Namibian officials said the provisions, as originally drafted, were “not in compliance with Namibia’s national laws” and violated constitutional protections governing privacy and national control over biological resources.
Both governments reportedly remain in negotiations over a revised bilateral health agreement.
The funding transition will proceed in accordance with Namibian law, according to their joint statement.
Washington Pursues Country-by-Country Agreements
The Trump administration has been negotiating individual health agreements with foreign governments, particularly in Africa.
Washington says the agreements are intended to reduce dependency on international donors, increase domestic healthcare spending and protect American interests.
The United States has signed agreements with approximately 30 countries since late 2025. However, proposed requirements governing health data and biological materials have encountered resistance.
Ghana rejected a proposed agreement over access to sensitive health information. Zimbabwe withdrew from a $367 million package because of similar concerns, while a court challenge has delayed Kenya’s $2.5 billion agreement.
Zambia has also objected to American data-sharing requirements.
Wider PEPFAR Drawdown Across Africa
The Namibia decision forms part of a broader restructuring of U.S. HIV assistance across southern Africa.
Washington recently announced that it would phase out more than $400 million in annual support for South Africa’s HIV programs.
The United States has also begun a broader “phased drawdown” of PEPFARwhich has supported HIV prevention, testing and treatment in dozens of countries for more than two decades.
PEPFAR is widely credited with saving more than 20 million lives. Independent health organizations have warned that abrupt funding disruptions can close clinics, reduce access to prevention services and leave patients without consistent treatment.
Namibia’s strong treatment results could make its transition less disruptive than those facing countries with larger funding gaps. Still, maintaining its progress will depend on whether the government can replace U.S. financing without interrupting treatment, testing and community-based prevention programs.
More on US News